drugset
drugset / Trial / NCT03979599

Safety and Efficacy of Magnesium Sulphate as an Adjuvant to Levobupivacaine in Ultra-sound Guided Transversus Abdominis Plan Block in Pediatric Abdominal Cancer Surgery

NCT03979599 ↗

Phase 3 Unknown 10 enrolled South Egypt Cancer Institute
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To study the efficacy of magnesium sulphate as adjuvant to levobupivacaine in transversus abdominis plane (TAP) block in patient undergoing abdominal cancer surgery.

Timeline

Start
2019-04-15
Primary completion
2023-06-01
Completion
2023-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified — Other
Comparator Levobupivacaine Other / unclassified 0.25 % Other

Indications

No indication recorded.